26 February 2019 - Republican senator says he can't understand sudden price jump of his Parkinson's medication.
Channeling the ire of constituents and drawing from personal experience, U.S. senators chastised drug company executives Tuesday over the high cost of prescription medications, while the pharmaceutical CEOs warned that government price controls could stifle breakthroughs on diseases like Alzheimer's disease.
The Senate finance committee hearing marked the first time lawmakers have called the industry's top executives to account for rising prices considered a drain on U.S. government health programs Medicare and Medicaid — and a burden to millions of Americans.